187 related articles for article (PubMed ID: 18922855)
1. NKp80 defines and stimulates a reactive subset of CD8 T cells.
Kuttruff S; Koch S; Kelp A; Pawelec G; Rammensee HG; Steinle A
Blood; 2009 Jan; 113(2):358-69. PubMed ID: 18922855
[TBL] [Abstract][Full Text] [Related]
2. Genetically coupled receptor-ligand pair NKp80-AICL enables autonomous control of human NK cell responses.
Klimosch SN; Bartel Y; Wiemann S; Steinle A
Blood; 2013 Oct; 122(14):2380-9. PubMed ID: 23929856
[TBL] [Abstract][Full Text] [Related]
3. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction.
Welte S; Kuttruff S; Waldhauer I; Steinle A
Nat Immunol; 2006 Dec; 7(12):1334-42. PubMed ID: 17057721
[TBL] [Abstract][Full Text] [Related]
4. Attenuated natural killer (NK) cell activation through C-type lectin-like receptor NKp80 is due to an anomalous hemi-immunoreceptor tyrosine-based activation motif (HemITAM) with impaired Syk kinase recruitment capacity.
Rückrich T; Steinle A
J Biol Chem; 2013 Jun; 288(24):17725-33. PubMed ID: 23609447
[TBL] [Abstract][Full Text] [Related]
5. Generation and preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of natural killer (NK) cells against leukemia.
Deng G; Zheng X; Zhou J; Wei H; Tian Z; Sun R
J Biol Chem; 2015 Sep; 290(37):22474-84. PubMed ID: 26198633
[TBL] [Abstract][Full Text] [Related]
6. Cellular Mechanisms Controlling Surfacing of AICL Glycoproteins, Cognate Ligands of the Activating NK Receptor NKp80.
Neuss S; Bartel Y; Born C; Weil S; Koch J; Behrends C; Hoffmeister M; Steinle A
J Immunol; 2018 Aug; 201(4):1275-1286. PubMed ID: 29980609
[TBL] [Abstract][Full Text] [Related]
7. Peptide mimicry of AICL inhibits cytolysis of NK cells by blocking NKp80-AICL recognition.
Huang H; Zheng X; Tian Z; Sun R
Immunol Invest; 2010; 39(6):587-97. PubMed ID: 20653426
[TBL] [Abstract][Full Text] [Related]
8. Tumor cells of non-hematopoietic and hematopoietic origins express activation-induced C-type lectin, the ligand for killer cell lectin-like receptor F1.
Akatsuka A; Ito M; Yamauchi C; Ochiai A; Yamamoto K; Matsumoto N
Int Immunol; 2010 Sep; 22(9):783-90. PubMed ID: 20663776
[TBL] [Abstract][Full Text] [Related]
9. The gp49B1 inhibitory receptor regulates the IFN-gamma responses of T cells and NK cells.
Gu X; Laouar A; Wan J; Daheshia M; Lieberman J; Yokoyama WM; Katz HR; Manjunath N
J Immunol; 2003 Apr; 170(8):4095-101. PubMed ID: 12682239
[TBL] [Abstract][Full Text] [Related]
10. Expression of inhibitory "killer cell lectin-like receptor G1" identifies unique subpopulations of effector and memory CD8 T cells.
Beyersdorf NB; Ding X; Karp K; Hanke T
Eur J Immunol; 2001 Dec; 31(12):3443-52. PubMed ID: 11745363
[TBL] [Abstract][Full Text] [Related]
11. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
12. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E
Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
[TBL] [Abstract][Full Text] [Related]
13. Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
Göthert JR; Eisele L; Klein-Hitpass L; Weber S; Zesewitz ML; Sellmann L; Röth A; Pircher H; Dührsen U; Dürig J
Cancer Immunol Immunother; 2013 Nov; 62(11):1697-1709. PubMed ID: 24022692
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy.
Derre L; Corvaisier M; Pandolfino MC; Diez E; Jotereau F; Gervois N
J Immunol; 2002 May; 168(10):4864-70. PubMed ID: 11994435
[TBL] [Abstract][Full Text] [Related]
15. HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity.
Peipp M; Derer S; Lohse S; Staudinger M; Klausz K; Valerius T; Gramatzki M; Kellner C
Oncotarget; 2015 Oct; 6(31):32075-88. PubMed ID: 26392331
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
17. Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes.
Spreu J; Kuttruff S; Stejfova V; Dennehy KM; Schittek B; Steinle A
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5100-5. PubMed ID: 20194751
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity.
Dennehy KM; Klimosch SN; Steinle A
J Immunol; 2011 Jan; 186(2):657-61. PubMed ID: 21149606
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of killer cell lectin-like receptor G1 expression on T cells.
Robbins SH; Terrizzi SC; Sydora BC; Mikayama T; Brossay L
J Immunol; 2003 Jun; 170(12):5876-85. PubMed ID: 12794113
[TBL] [Abstract][Full Text] [Related]
20. CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients.
Makwana N; Foley B; Fernandez S; Lee S; Irish A; Pircher H; Price P
Eur J Immunol; 2017 Aug; 47(8):1324-1334. PubMed ID: 28586095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]